Abrams P, Wein AJ. The overactive bladder and incontinence. Neurourol Urodyn 1999; 18: 413-416.
Abrams P, Cardozo L, Fall M, et al. The standardization of terminology of lower urinary tract function: Report from the standardization sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167-178.
Stewart W, Herzog R, Wein A, et al. on behalf of the NOBLE Program Research Team. Prevalence and impact of overactive bladder in the US: Results from the NOBLE program. Neurourol Urodyn 2001; 20 (4): Abstract 24.
Thom D. Overactive bladder: Epidemiology and impact on quality of life. Patient Care 2000; (Winter): 6-14.
Leidy NK, Revicki DA, Geneste B. Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value Health 1999; 2: 113-127.
Pleil A, Reese PR, Kelleher CJ, Okano GJ. Health-related quality of life of patients with overactive bladder receiving immediate release tolerodine. Health Econ Prev Care (HEPAC) 2001; 2: 69-75.
Brown J, Posner S, Stewart A. Urge incontinence: New health-related quality of life measure. J Am Geriatr Soc 1999; 47: 980-988.
Lubeck D, Prebil L, Peeples P, Brown J. A health-related quality of life measure for use in patients with urge urinary incontinence: A validation study. Qual Life Res 1999; 8: 337-344.
Grimby A, Milsom I, Molander U, et al. The influence of urinary incontinence on the quality of life of elderly women. Age Ageing 1993; 22: 82-89.
Hunskaar S, Vinsnes A. The quality of life in women with urinary incontinence as measured by the sickness impact profile. J Am Geriatr Soc 1991; 39: 378-382.
Kobelt G, Kirchberger I, Malone-Lee J. Quality-of-life aspects of the overactive bladder and the effect of treatment with tolterodine. BJU Int 1998; 83: 583-590.
O'Conor R, Johannesson M, Hass S, Kobelt-Nguyen G. Urge incontinence: Quality of life and patients' valuation of symptom reduction. Pharmacoeconomics 1998; 14(5): 531-539.
Wyman J, Harkins S, Choi S, Taylor J, Fantl A. Psychosocial impact of urinary incontinence in women. Obstet Gynecol 1987; 70: 378-381.
Jolleys JV, Donovan JL, Nanchahal K, Peters TJ, Abrams P. Urinary symptoms in the community: How bothersome are they? Br J Urol 1994; 74: 551-555.
Jackson S, Donovan J, Brookes S, Eckford L, Swithinbank L, Abrams P. The Bristol female lower urinary tract symptoms questionnaire: Development and psychometric testing. Br J Urol 1996; 77: 805-812.
Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol 1997; 104: 1374-1397.
Lee P, Reid D, Saltmarche A, Linton L. Measuring the psychosocial impact of urinary incontinence: The York incontinence perceptions scale (YIPS). J Am Geriatr Soc 1995; 43: 1275-1278.
Shumaker S, Wyman JF, Uebersax JS, McClish D, Fantl JA. Health-related quality of life measures for women with urinary incontinence: The incontinence impact questionnaire and the urogenital distress inventory. Qual Life Res 1994; 3: 291-306.
Wagner TH, Patrick DL, Bavendam TB, Martin ML, Buesching DP. Quality of life of persons with urinary incontinence: Development of a new measure. Urology 1996; 47(1): 67-72.
DuBeau C, Kiely D, Resnick N. Quality of life impact of urge incontinence in older persons: A new measure and conceptual structure. J Am Geriatr Soc 1999; 47: 989-994.
Norton PA, MacDonald LD, Sedgwick PM, Stanton SL. Distress and delay associated with urinary incontinence, frequency, and urgency in women. BMJ 1998; 297: 1187-1189.
Robinson D, Pearce K, Preisser J, Dugan E, Suggs P, Cohen S. Relationship between patient reports of urinary incontinence symptoms and quality of life measures. Obstet Gynecol 1998; 91: 224-228.
Liberman JN, Hunt TL, Stewart WF, et al. Health-related quality-of-life among adults with symptoms of overactive bladder: Results from a US community-based survey. Urology 2001; 57(6): 1044-1050.
Coyne K, Schmier J, Hunt T, Corey R, Liberman J, Revicki D. Developing a specific HRQL instrument for overactive bladder. Value Health 2000; 3: 141.
Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health survey manual and interpretation guide. Boston: New England Medical Center, The Health Institute, 1993.
Hays RD, Stewart AL. Sleep measures. In: Stewart AL, Ware JE Jr (eds), Measuring Functioning and Well-being: The Medical Outcomes Study Approach. Durham, NC: Duke University Press, 1992; 235-259.
Harati Y, Gooch C, Swenson M, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998; 50: 1842-1846.
Payne R, Mathias SD, Pasta DJ, Wanke LA, Williams R, Mahmoud R. Quality of life and cancer pain: Satisfaction and side effects with transdermal fentanyl versus oral morphine. J Clin Oncol 1998; 16: 1588-1593.
Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385-401.
Radloff LS, Teri L. Use of the center for epidemiological studies-depression scale with older adults. Clin Gerontol 1986; 5: 119-136.
Hays RD, Hayashi T. Beyond internal consistency reliability: Rationale and user's guide for Multitrait Analysis program on the microcomputer. Behav Res Meth Instr Comp 1990; 22: 167-175.
Mulaik SA. The foundations of factor analysis. New York: McGraw-Hill, 1972.
Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297-334.
Donovan J. Measuring the impact of nocturia on quality of life. BJU Int 1999; 84: 21-25.
Revicki DA, Osoba D, Fairclough D, et al. Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual Life Res 2000; 9: 887-900.